Finding Opportunities in the Market Sell-Off, Corning’s Vaccine Effort, The Day Trader Effect

FromThe Exchange

Start listening View podcast show

Finding Opportunities in the Market Sell-Off, Corning’s Vaccine Effort, The Day Trader Effect

FromThe Exchange

ratings:

Length:

47 minutes

Released:

Jun 11, 2020

Format:

Podcast episode

Description

With the Dow falling more than 5% in its worst drop since mid-March, one trader tells us which names he’s cherry picking amid the sell-off.And the CEO of Corning joins to discuss how his company is joining the fight to find a coronavirus vaccine as biotech companies make big advances in potential treatments.Plus, we take a look at the effect the surge in day trading has had on the market and whether it spells more froth ahead.

Released:

Jun 11, 2020

Format:

Podcast episode

More Episodes from The Exchange

Skip carousel

Rate debate, un-welcoming party?, and Credit Suisse bets on bubbles: We’re just an hour away from getting the minutes from the latest Fed meeting, where the FOMC started to sound hawkish. We’ll debate which way rates go next. Plus, Chinese stocks are selling off again today. Did U.S. investors overestimate how committed China was to capitalism? We’ll explore how ‘welcoming’ (or not) it’s becoming to outside investors. And, in today’s Rapid Fire: more people are paying with crypto, some people are working less but getting paid the same, and Credit Suisse is betting more people will begin drinking hard seltzer. by The Exchange
44 min listen
China crackdown, ‘no deal’ and tech turmoil: China is cracking down on its own companies, starting with ride share firm Didi. Why are they doing it, and what does it mean for investing in China? We’ll explore. Plus, the OPEC nations met but left without making a deal. With oil already at 6-year highs, could $100 per barrel come next? We’ll ask Jeff Currie of Goldman Sachs. And, big tech is getting a boost with Amazon, Microsoft, Alphabet and Facebook hitting all-time highs despite growing regulatory scrutiny. Is the growth trade back? We’ll debate. by The Exchange
44 min listen
Taper Timeline, Billionaire Space Race and Boosts, Batteries, and Bezos: The economy adding 850k jobs in June, does this move up the Fed’s tapering timeline? Bank of America’s Head of Economics, Michelle Meyer, weighs in. It’s Bezos versus Branson in the race to space with Branson poised to become the first billionaire to fly to the stars…we have the details. And Jeff Bezos will have plenty of time on his hands soon as he steps down as Amazon CEO, what the company looks like without him at the helm. Plus, Uber offering big driver incentives as it faces a shortage, GM’s big EV investment and bitcoin mining made easier…all that in today’s Rapid Fire. by The Exchange
44 min listen
Collision course?, “timber!” and a donut debut: Chinese President Xi-Jinping just delivered a fiery speech aimed in part at the U.S. We’ll explore what it means for doing business and investing in China. Plus, lumber prices have gotten chopped in half since hitting their May peak. We’ll explain why it’s happening, and what it also says about inflation. And, in today’s Rapid Fire: Instagram wants to be more like TikTok, Robinhood wants you to use Robinhood to buy Robinhood stock, and Krispy Kreme goes public. by The Exchange
45 min listen
The space race, cleanup in all aisles and IPO-verload: One of Sir Richard Branson’s space companies launched satellites into orbit today, while the other just got cleared for commercial travel. Will he beat Jeff Bezos into flight? We’ll ask him. Plus, Bed Bath & Beyond CEO Mark Tritton has made it his mission to clean up its stores. The early returns are good, but can the stock return to its Reddit-fueled highs? We’ll explore. And, while SPACs have simmered down lately, the IPO market is heating back up. China’s Didi debuted today with Legal Zoom, SentinelOne and Krispy Kreme all on deck. We’ll discuss. by The Exchange
45 min listen
Too much for Medicare?, hot, hot housing and America’s ammo shortage: Biogen’s new Alzheimer’s Disease drug is being hailed as a medical breakthrough. But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate. Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April. Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO. And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore. by The Exchange
45 min listen
Overdue for a pullback?, the EV battle and Real or Reddit?: The Nasdaq and S&P 500 both hit record highs today. Will we ever see a pullback in the market again? We’ll ask the experts. Plus, it seems electric vehicles are here to stay. One analyst joins to explain why he’s betting on Ford as the next big winner in the EV space. And, shares of Blackberry have nearly doubled this year as the company gets caught up in ‘Meme Mania.’ Is the rally for real, or just a Reddit-fueled spike? We’ll debate. by The Exchange
45 min listen
The ‘Buy Everything’ Market, Rent Reality and the Future of Work: Both growth and value are moving higher this week, 10 of the 11 S&P sectors are in the green and commodities are climbing…so where are the opportunities? A strategists reveals his picks. The Biden administration extended the eviction moratorium through the end of July, we discuss what this means for the small landlords who are still awaiting federal aid. And as more people return to the office, we look at the future of work with a former Yahoo! executive who had a change of heart on the importance of the office. by The Exchange
45 min listen
The Exchange - 06/24/21: Listen to the day's top stories, the must reads & a whole lot more for today's modern investor. by The Exchange
44 min listen
Forget F.A.N.G., (don’t) follow the leader, and Alcoa’s revenge: Microsoft just became the 2nd member of the exclusive $2 trillion club. Could it surpass Apple as the top tech titan next? We’ll debate. Plus, one strategist says following the investment crowd into growth names and big tech is a mistake right now. He’ll join us to explain why. And, in today’s Rapid Fire: a retail stock that could rally 50% from here, Warby Parker “eyeing” a direct listing and Alcoa’s market revenge. by The Exchange
45 min listen
All eyes on Powell, a market disaster and the crypto collapse: Federal Reserve Chair Jerome Powell is set to testify today, as investors weigh his words of continued support against changing course. We’ll bring you the latest details. Plus, we’ll reveal what one economist says is the number one thing the Fed can do right now that would be a complete disaster for financial markets. And, Bitcoin briefly dipped below $30,000 for the first time since January amid another volatile session. Will it ever get back to previous all-time highs? We’ll debate. by The Exchange
44 min listen
Rate threat, searching for bargains and “try the thigh”: The Fed’s heightened concern about inflation ironically sent the bond market headed downward, with yields hitting multi-month lows. We’ll explain why. Plus, Amazon’s Prime Day kicks off today and while the products may be cheap, the stock’s been the real bargain. We’ll give you three name that could be the next big scores. And, the chicken wing shortage has gotten so bad, Wingstop is now launching a new brand: Thighstop. We’ll speak to the CEO about its pivot to new offerings. by The Exchange
44 min listen
Inflation rotation, green growing pains and a soda snub: The inflation trade is collapsing today, as the Fed gets a little more aggressive. We’ll tell you what moves to make right now. Plus, a lot of investors have been piling into ESG stocks lately. But what exactly IS an ESG stock? We’ll define it for you. And, in today’s ‘star-studded’ Rapid Fire: Jessica Alba’s stock slide, and Cristiano Ronaldo’s big soda snub. by The Exchange
45 min listen
Pricing pressure, earning their ‘stripes’ and appetite for an IPO: We just got yet another report showing food, energy & many other products costing more. But has inflation already peaked? We’ll debate. Plus, Stripe is fast becoming the hottest unicorn on the market. But as it prepares for an IPO, is the best already priced in? We’ll explore. And, in today’s Rapid Fire: Amazon’s grocery games, Chobani’s IPO aspirations and Zillow’s new ‘Zestimates’. by The Exchange
45 min listen
Breaking up big tech, green gone wrong?, and the end of the Millennial lifestyle: Lawmakers are setting the stage for a crackdown on big tech. But would forcing a Facebook split from Instagram really be a punishment? We’ll debate. Plus, will the recent push for clean energy send oil prices soaring? We’ll explore, and tell you who could feel the pinch the most. And, the quest for profitability in Silicon Valley is having an unintended side effect: the end of the “Millennial lifestyle” as we know it. We’ll explain. by The Exchange
45 min listen
Rotating back?, sticker shock and boom or bust for NFTs: Growth has been outperforming again over the past month as more experts turn bullish on Tech. We’ll ask a top Value manager to respond to the rotation situation. Plus, from your breakfast bacon to your afternoon coffee, consumers are feeling the squeeze of inflation. We’ll walk you through all the parts of your day where you might be feeling the pinch. And, the NFT business seemingly exploded overnight, but has started to dissipate almost as quickly. We’ll explore why, and whether digital art is a smart place to put your money. by The Exchange
45 min listen
Market disconnect, The Street vs. Reddit, and a big bitcoin bet: Inflation has surged to the highest level in more than a decade. So why are stocks rallying and bond yields stuck in place? We’ll explore the disconnect. Plus, Bank of America is downgrading Clover to “Underperform” after its Reddit-fueled run up. We’ll explore the latest developments in this Wall St. tug-of-war.And, in today’s Rapid Fire: Starbucks is running out of cups, consumers behaving badly and cryptocurrencies coming soon to your 401(k). by The Exchange
40 min listen
Real or Reddit?, a net zero community, and time to retire “FANG”?: We’ve all heard of Gamestop, AMC and other “meme” stocks by now. We’ll dig deeper into Reddit and find the under-the-radar plays that still exist. Plus, a massive carbon-neutral housing project is now underway in California. We’ll tell you what it means for both residents and investors there. And, is it time to retire “FANG”? One market strategist says the trade is over, but its inventor – CNBC’s own Jim Cramer – disagrees. We’ll debate. by The Exchange
45 min listen
All about “flation”, lumber gets whacked and price shock ahead?: The focus on the street right now is all about “flation” – but which kind? Inflation, reflation or deflation? We’ll look at the latest economic data and figure out exactly which “flation” is winning the day. Plus, lumber prices keep dropping and are now down about 30% from their highs. Is wood no longer good? We’ll debate. And, a fresh Covid-19 outbreak in China could mean big delays – and price hikes – for your goods. We’ll bring you the key details. by The Exchange
45 min listen
Apple takes the stage, as good as it gets?, and the same-day surge: CEO Tim Cook is taking the stage at Apple’s developers conference today. We’ll highlight how the tech giant can get its goodwill back with them after some recent setbacks. Plus, while some experts say a rally higher won’t happen, one strategist says there’s more gains ahead for the market. He’ll join us with what will drive the next leg higher. And, just when you thought the delivery wars couldn’t get any hotter, Morgan Stanley says same-day shipping is about to go mainstream. We’ll give you their top pick to lead the way. by The Exchange
46 min listen
Not betting on tech, electric earnings and a wild ride: One 5-star fund manager is far outpacing the market this year, and the gains haven’t come from high-flying names. He’ll tell us what he’s buying. Plus, ChargePoint shares are higher after strong revenue and guidance. We’ll speak with the CEO about the EV surge and what it means for the company. And, “Meme Mania” came roaring back with a bang, including multiple stock sales and millions of shares issued for AMC. We’ll look back at its wild week. by The Exchange
45 min listen
Meme madness, charged up and a stealth EV play: A new question is emerging amid the meme stock madness: are investors getting played? We’ll search for some answers. Plus, as more legacy players dive into the EV space, one area that could benefit in a big way are charging stocks. We’ll speak with the CEO of Blink Charging. And, in today’s Rapid Fire: Twitter’s subscription strategy, Blackberry’s auto ambitions and Apple wants workers back in the office. by The Exchange
45 min listen
Straight to shareholders, back online and the need for speed: AMC trading got halted today as shares surged above $60, just after it launched a platform exclusively for its retail investors. We’ll explore the perks and the pitfalls of trading in this “meme” monster, and who’s pocketing the big bucks right now. Plus, The White House says nothing is off the table in responding to the ransomware attack on meat producer JBS. We’ll give you the details. And, the nation’s largest fast-charging EV network is set to go public via SPAC. The CEO of EVgo joins to discuss its forthcoming debut and the EV surge here at home. by The Exchange
44 min listen
The summer setup, box office bounce back and rearview mirror returns: The past few weeks have seen stocks return to near all-time highs, while Small Caps are enjoying their longest monthly winning streak since 1995. Are we headed for more of the same? Or will oil, crypto or another surprise sector spoil the party? We’ll ask our market experts. Plus, consumers are flocking back to theaters in droves as a fresh slate of movies hits the big screen. Is the box office officially back? We’ll debate. And, President Biden is considering a retroactive capital gains tax hike. We’ll explore the fallout if it happens -- especially for crypto investors. by The Exchange
44 min listen
The call heard around Wall St., “can’t rise fast enough” and hot hospitality: One expert is out with a major warning on Apple, saying iPhone 12 sales will miss expectations and the stock is a “sell.” He’ll join us. Plus, another analyst says prices can’t rise fast enough in the housing market right now. He’ll join us to explain why. And, hospitality is headed for a hot summer as the economy reopens, but the ongoing worker shortage could spell trouble ahead. We’ll discuss. by The Exchange
45 min listen
An auto revolution, reopening buzz and inflation hits Main Street: The auto industry is at a turning point as EVs go mainstream, D.C. dangles more incentives and prices keep surging. Who will come out on top as the industry evolves? We’ll ask our experts, and their answers may surprise you. Plus, we’ll speak to the CEO of Molson Coors about sales, its hard seltzer push and its recent ransomware attack. And, new data reveals the impact that inflation is having on businesses and consumers up and down Main Street. We’ll explain. by The Exchange
41 min listen
Mining for gains, falling behind?, and DC enters the debate: “Meme stocks” are roaring back and cryptos are rebounding too. But is there a way to play the space without all of the volatility? We’ll look at companies that *mine* bitcoin, and speak with an analyst who says one of his picks could rally more than 80% from here. Plus, hundreds of smaller banks are now offering access to crypto, while the big banks seem to be falling behind. Can they catch up? We’ll debate. And, inflation is turning into a political tactic on Capitol Hill, with Republican lawmakers using it to target President Biden’s economic agenda. We’ll give you the key details. by The Exchange
45 min listen
Amazon under fire, too large to handle?, and burnout buildup: The D.C. Attorney General just filed a lawsuit against Amazon, claiming its price controls are anti-competitive. We’ll speak with the AG live in a First On CNBC interview. Plus, Intel’s new CEO has managed to accomplish more in his first 100 days than the company had in years. But is it enough to bring the company back? We’ll debate. And, a new survey found 44% of professionals think they’re more burned out on the job today than they were a year ago. We’ll explain why that could be a boon for travel companies. by The Exchange
45 min listen
Buying the dip, running out of luck?, and the fight for 15%: A wild weekend of trading led to a crypto crash. We’ll look at who could be buying the dip here, and whether or not you should get in too. Plus, we’ve seen a bunch of other speculative blowups this year, from SPACs to FOMO stocks. Can the broader averages avoid a similar fate? We’ll explore. And, the White House is proposing a 15% global minimum corporate tax rate to put a halt to the race for the lowest figure. We’ll give you the key details. by The Exchange
45 min listen
Pandemic productivity boom, red hot housing and slash, substitute, swipe: There’s a pandemic productivity boom underway, with the U.S. doing more with fewer workers than ever before. We’ll look at what that could mean for markets, jobs, inflation – and the Federal Reserve, too. Plus, the housing market continues to be red hot. We’ll speak with the CEO of Realogy about trends they’re seeing, and its surging stock price. And, in today’s Rapid Fire: a 20% price cut for Tesla; another change for the Dow?; and the White House ‘swipes right’ to get people vaccinated. by The Exchange
45 min listen

Related podcast episodes

Skip carousel

Sorrento CEO, BioReference CEO And The Great Outdoors: As Sorrento Therapeutics gains FDA approval for phase two of their COVID-19 treatment, how should investors approach the stock? CEO Dr. Henry Ji checks in to discuss the company's latest developments against coronavirus after today's 20% gain. Then, BioReference Labs CEO Dr. Jon Cohen joins Cramer to talk about testing the NBA, major league soccer, and expanding testing throughout the U.S. as the pandemic continues. Plus, Cramer's revealing 4 stocks in the outdoor space that could be worth looking at. by Mad Money w/ Jim Cramer
47 min listen
Markets Rally, Salesforce CEO, Perrigo CEO, & Biohaven CEO: The DOW rallied over 700 points today, and Jim Cramer is looking into which companies could be positioned to do well when the country opens back up for business. Then, the CEO of Salesforce, Marc Benioff joins Cramer to talk corporate responsibility and his company’s relief efforts in the face of the pandemic. Next, after pre-announcing its first quarter earnings results, Perrigo CEO, Murray Kessler, talks to Cramer about how the company is handling the surge in demand for generic over-the-counter self-care drugs. Plus, an exclusive with the CEO of Biohaven, Vlad Couric, on the launch his company’s new migraine treatment. by Mad Money w/ Jim Cramer
47 min listen
A closer look at 2023's top biopharma deals and what lies ahead by The Top Line
18 min listen
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. by Business Of Biotech
67 min listen
Commercial Readiness with Orca Bio's Dan Kirby by Business Of Biotech
52 min listen
Six biopharma executives consider a tough 2023 and are hopeful for a better 2024: One aspect of 2023 our group of executives completely agreed on: the past year was tough financially. And they all foresee see a more vibrant year ahead for the market. Giving all of them hope were technological breakthroughs such as artificial... by The BioWorld Insider Podcast
17 min listen
U.S. FDA Authorized Booster Dose Of MRNA & PFE by Schwab Network
7 min listen
Episode 56 by Biotech Hangout
63 min listen
Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer by Business Of Biotech
57 min listen
How Far Back Does the Pharma Rot Go? | Guest: Dr. Pierre Kory | 4/14/22 by Conservative Review with Daniel Horowitz
74 min listen
Domino's CEO, Inovio Pharmaceuticals CEO, & Digging Into UNH: Fresh off the company's top and bottom line beat, Cramer's checking in with the CEO of Domino's Pizza to learn more about how the company's delivering in a new environment. Then, after learning that Inovio Pharmaceuticals was one of the most-bought stocks on Robinhood in March, Cramer's talking to the company's CEO to learn more about its path towards finding a vaccine for COVID-19. Plus, Cramer's breaking down UnitedHealth Group's recent earnings to see if there are any insights investors should use to help in building their thesis. by Mad Money w/ Jim Cramer
47 min listen
DOW Surges Over 500 Points, GSK CEO & Bioreference CEO: The market rallied today and Cramer is diving into the coronavirus developments and the impact on business. Then, an exclusive interview with GSK CEO, Emma Walmsley, on the announcement of the company’s historic collaboration with Sanofi to develop and produce a vaccine for COVID-19. And, Cramer goes off the carts to examine how the pandemic is affecting the defense industry. Plus, Dr. Jon Cohen, executive chairman of BioReference Laboratories, joins the program to discuss the state of drive-thru testing in New York and New Jersey and what it means for mass testing roll outs across the country. by Mad Money w/ Jim Cramer
47 min listen
The Death of “Blockbuster” Products: Micro Launches and a Data-driven Approach to Marketing with Indraneel Mukherjee, Associate Partner at ZS Associates by Pharma Launch Secrets
37 min listen
As biopharma deals keep pace, M&A volumes languish by The BioWorld Insider Podcast
14 min listen
SQUAWK BOX, WEDNESDAY 15TH JULY, 2020 by Squawk Box Europe Express
25 min listen
April 21, 2023 by The Top Line
22 min listen
Episode 93 by Biotech Hangout
63 min listen
UK's NHS Backs World's Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats by Xtalks Life Science Podcast
26 min listen
The ATMP and CDMO deal maker: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Anderson, General Partner at Ampersand Capital Partners. Your host, Raman Sehgal, discusses the pharmaceutical and biotechn... by Molecule to Market: Inside the outsourcing space
54 min listen
Ep 940 | The FDA’s Sneaky, Unethical, and Dangerous 'Approval' of Vaccine by Conservative Review with Daniel Horowitz
67 min listen
Game Plan, Anaplan CEO, Biohaven Pharma CEO, & Centene CEO: Despite a phase one trade deal with China, the Dow remained steady today, rising only 3 points, and Jim Cramer’s giving you his Game Plan to navigate next week on Wall Street. Then, Anaplan CEO Frank Calderoni sits down to talk about the stock’s recent roar, up 90% for the year, and where the company is headed from here. Then, Dr. Vlad Coric, CEO of Biohaven Pharmaceuticals is in the Mad Money studio to talk about what’s in the company’s pipeline and what it means for the company’s future. And, what should you make of the managed care company’s heading into 2020? Cramer’s talking with Centene’s CEO, Michael Neidorff, to discuss the stock’s recent decline how you should interpret the company’s new guidance and its acquisition of WellCare. by Mad Money w/ Jim Cramer
43 min listen
The virotherapy virtuoso: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, Chief Executive Officer at Vibalogics. Who is this dynam... by Molecule to Market: Inside the outsourcing space
48 min listen
Watching the Trade Tea Leaves, Biotech M&A Monday & Coca-Cola CEO Exclusive: David Faber & Jim Cramer discuss the hopes for a China-U.S. trade deal, as stocks fall for the first time in four days. Plus, Biotech M&A as both Merck and Sanofi move to boost their oncology pipelines. And Coca-Cola CEO James Quincey joins exclusively to discuss trade, his growth strategy and 100 years as a public company. by Squawk on the Street
42 min listen
The big pharma sourcing specialist: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Daniel Hogan, External Manufacturing Team Lead for the Americas at Bayer Pharmaceuticals. Your host, Raman Sehgal, discusses the phar... by Molecule to Market: Inside the outsourcing space
44 min listen
Industry Calls for New Incentives to Spur Development of New Antibiotics: As concerns grow about the rise of antibiotic resistant bugs, the ability to combat them is being undermined by the economics of antibiotic drug development. Many large pharmaceutical companies stepped away from the space and despite the passage of t... by The Bio Report
22 min listen
Pharma and Biotech Daily: Your Essential Industry Update by Pharma and BioTech Daily
3 min listen
Trust, Digital Innovation, Metaverse and Pharma Launches: What is the Connection? with Brendan Gallager of Publicis Health: In this episode of Pharma Launch Secrets, Bozidar is joined by Brendan Gallagher, Chief Connected Health Officer at Publicis Health. They discuss the impact of the pandemic on pharma and biotech companies and how COVID-19 is driving them to evolve their product launch strategy. by Pharma Launch Secrets
31 min listen
Episode 9: A Between the Biotech Waves Conversation with Yaron Werber, MD of Healthcare Biotechnology at Cowen. by Between the Biotech Waves
52 min listen
The big rollout, vaccine bullishness and crude’s incredible comeback: Pfizer’s COVID-19 vaccine has begun rolling out at hospitals across the nation. We’ll speak to Walgreens’ VP of Pharmacy Operations about how and when the public will start receiving it. Plus, the Dow is trading above its record close as investors buy into renewed stimulus talks. Should you bet on its passage? We’ll discuss. And, crude is rallying as Gold’s glitter fades. We’ll ask Goldman Sachs’ Jeff Currie why, and what he thinks of these moves. by The Exchange
45 min listen
5 Big Reveals from the 2022 JP Morgan Healthcare Conference by The 7investing Podcast
24 min listen

Discover this podcast and so much more

Finding Opportunities in the Market Sell-Off, Corning’s Vaccine Effort, The Day Trader Effect

Finding Opportunities in the Market Sell-Off, Corning’s Vaccine Effort, The Day Trader Effect

Description

More Episodes from The Exchange

Related podcast episodes